Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma

Effect of alternative splicing (AS) on diffuse large B-cell lymphoma (DLBCL) pathogenesis and survival has not been systematically addressed. Here, we compared differentially expressed genes and exons in association with survival after chemoimmunotherapy, and between germinal center B-cell like (GCB...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Cancer J
Päätekijät: Leivonen, S-K, Taskinen, M, Cervera, A, Karjalainen-Lindsberg, M-L, Delabie, J, Holte, H, Lehtonen, R, Hautaniemi, S, Leppä, S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596382/
https://ncbi.nlm.nih.gov/pubmed/28841210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.71
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia